133 related articles for article (PubMed ID: 4909406)
1. [Current status of drug-resistant bacteria and the treatment of refractory infections].
Matsuda S
Sanfujinka No Jissai; 1970 Feb; 19(2):182-91. PubMed ID: 4909406
[No Abstract] [Full Text] [Related]
2. Laboratory and clinical evaluation of rifampicin.
Atlas E; Turck M
Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028
[No Abstract] [Full Text] [Related]
3. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections].
Chamfeuil R; Curcier H
Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534
[No Abstract] [Full Text] [Related]
4. [Hospitalism in urology].
Lipsky H
Med Klin; 1970 Oct; 65(42):1833-8. PubMed ID: 4997048
[No Abstract] [Full Text] [Related]
5. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967].
Diana L; Romano M; Perin G
Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607
[No Abstract] [Full Text] [Related]
6. [Development of resistance. Problems of chemotherapy in urology].
Engel D
Z Arztl Fortbild (Jena); 1977 Sep; 71(18):843-5. PubMed ID: 413268
[No Abstract] [Full Text] [Related]
7. Changing incidence of antibiotic resistance among Staphylococcus aureus, Escherichia coli, Aerobacter-Klebsiella, and Pseudomonas encountered in a teaching hospital over a 7-year period.
Bulger RJ; Roberts CE; Sherris JC
Antimicrob Agents Chemother (Bethesda); 1966; 6():42-6. PubMed ID: 4860771
[No Abstract] [Full Text] [Related]
8. [Resistance to rifampicin. In vitro and in vivo studies].
Bouanchaud DH; Acar JF
Pathol Biol (Paris); 1969; 17(15):763-7. PubMed ID: 4907911
[No Abstract] [Full Text] [Related]
9. [Problems of ambulatory pharmacotherapy. 8. A model for antibiotik-rank series in urinary tract infections].
Bark M; Essigke G; Kunze M; Rohmann EM; Meyer FP; Lauf H; Hudemann H; Walther H
Z Arztl Fortbild (Jena); 1977 Feb; 71(3):119-22. PubMed ID: 403689
[No Abstract] [Full Text] [Related]
10. The clinical use of nalidixic acid. A review and some observations.
Stamey TA; Nemoy NJ; Higgins M
Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942
[No Abstract] [Full Text] [Related]
11. [Clinical and bacteriological studies on the course of 31 cases of most severe chronic urinary tract infections during mainly discordant cephalexin medication].
Breitfellner G; Gasser G; Hauke D
Schweiz Rundsch Med Prax; 1973 Mar; 62(12):366-78. PubMed ID: 4570646
[No Abstract] [Full Text] [Related]
12. [Changes in the antibiotic resistance of pathogenic bacteria during 1967-1970].
Boldogh I; Boján M
Orv Hetil; 1972 Feb; 113(7):374-7. PubMed ID: 4551651
[No Abstract] [Full Text] [Related]
13. Treatment trials in urinary tract infection (UTI) with special reference to the effect of antimicrobials on the fecal and periurethral flora.
Winberg J; Bergström T; Lincoln K; Lidin-Janson G
Clin Nephrol; 1973; 1(3):142-8. PubMed ID: 4593447
[No Abstract] [Full Text] [Related]
14. Resistance to quinolones in pathogens causing urinary tract infections.
Kapoor H; Aggarwal P
J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy for infectious diseases. Progress in the last several years].
Shimizu K
Naika; 1967 Jun; 19(6):1011-6. PubMed ID: 4865493
[No Abstract] [Full Text] [Related]
16. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report].
Schmid W
Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223
[No Abstract] [Full Text] [Related]
17. [Urinary tract infection and aminobenzyl penicillin].
Furusawa T; Higashi T; Mishina T; Murakami T; Yasui A
Hinyokika Kiyo; 1968 Mar; 14(3):230-5. PubMed ID: 4877166
[No Abstract] [Full Text] [Related]
18. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
19. Cell lipids and sensitivity of bacteria to antibiotics.
Mordarska H; Tkaczowa A; Matej M; Mordarski M
Arch Immunol Ther Exp (Warsz); 1968; 16(2):219-27. PubMed ID: 4874470
[No Abstract] [Full Text] [Related]
20. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G; Wiedmer E
Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
